Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin
Clinical trial NCT03671538 · UNKNOWN
Trial details
- NCT number
- NCT03671538
- Sponsor
- Lingyu Luo
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2019-08-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.